BOTOX (Allergan, Inc.)


Welcome to the PulseAid listing for the BOTOX drug offered from Allergan, Inc.. This Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Allergan, Inc.
NON-PROPRIETARY NAME: onabotulinumtoxinA
SUBSTANCE NAME: BOTULINUM TOXIN TYPE A
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA]
ROUTE: INTRADERMAL; INTRAMUSCULAR
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1989-12-15
END MARKETING DATE: 0000-00-00


BOTOX HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBOTOX from Allergan, Inc.
LABELER NAME: Allergan, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100([USP’U]/1)
START MARKETING DATE: 1989-12-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0023-1145_e3d7b38d-cd47-4c2f-8808-e298499a7ba8
PRODUCT NDC: 0023-1145
APPLICATION NUMBER: BLA103000

Other BOTULINUM TOXIN TYPE A Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan, Inc.BOTOX
Galderma Laboratories, L.P.Dysport
Ipsen Biopharmaceuticals, Inc.Dysport
Merz North America, Inc.Xeomin
Merz Pharmaceuticals, LLCXeomin